chr6-132297788-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015529.4(MOXD1):c.1676C>T(p.Ser559Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000102 in 1,592,110 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
MOXD1
NM_015529.4 missense, splice_region
NM_015529.4 missense, splice_region
Scores
10
9
Splicing: ADA: 0.9967
2
Clinical Significance
Conservation
PhyloP100: 5.49
Genes affected
MOXD1 (HGNC:21063): (monooxygenase DBH like 1) Predicted to enable copper ion binding activity and dopamine beta-monooxygenase activity. Predicted to be involved in dopamine catabolic process; norepinephrine biosynthetic process; and octopamine biosynthetic process. Part of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MOXD1 | NM_015529.4 | c.1676C>T | p.Ser559Leu | missense_variant, splice_region_variant | 11/12 | ENST00000367963.8 | |
MOXD1 | XM_017010714.3 | c.1571C>T | p.Ser524Leu | missense_variant, splice_region_variant | 11/12 | ||
MOXD1 | XM_047418621.1 | c.1415C>T | p.Ser472Leu | missense_variant, splice_region_variant | 11/12 | ||
MOXD1 | XM_047418622.1 | c.1415C>T | p.Ser472Leu | missense_variant, splice_region_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MOXD1 | ENST00000367963.8 | c.1676C>T | p.Ser559Leu | missense_variant, splice_region_variant | 11/12 | 1 | NM_015529.4 | P1 | |
MOXD1 | ENST00000336749.3 | c.1472C>T | p.Ser491Leu | missense_variant, splice_region_variant | 10/11 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152100Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
15
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000911 AC: 21AN: 230544Hom.: 0 AF XY: 0.000120 AC XY: 15AN XY: 124864
GnomAD3 exomes
AF:
AC:
21
AN:
230544
Hom.:
AF XY:
AC XY:
15
AN XY:
124864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000102 AC: 147AN: 1440010Hom.: 0 Cov.: 30 AF XY: 0.000103 AC XY: 74AN XY: 716200
GnomAD4 exome
AF:
AC:
147
AN:
1440010
Hom.:
Cov.:
30
AF XY:
AC XY:
74
AN XY:
716200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74284
GnomAD4 genome
AF:
AC:
15
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74284
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2023 | The c.1676C>T (p.S559L) alteration is located in exon 11 (coding exon 11) of the MOXD1 gene. This alteration results from a C to T substitution at nucleotide position 1676, causing the serine (S) at amino acid position 559 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at